In line with this concept, we validated the induction of ID1 and CyclinD1 expression in HCC cells by administering recombinant BMP9 protein, leading to the facilitation of G1/S phase cell cycle progression. The gene discussed is GDF2; the disease is hepatocellular carcinoma.